| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 161.19K | AU$ 583.45K | AU$ 891.08K | AU$ 3.39M | AU$ 4.73M |
| Gross Profit | AU$ -204.21K | AU$ 446.32K | AU$ 203.70K | AU$ 1.45M | AU$ 1.81M |
| Operating Income | AU$ -7.39M | AU$ -15.44M | AU$ -18.26M | AU$ -15.60M | AU$ -14.26M |
| EBITDA | AU$ -7.23M | AU$ -17.00M | AU$ -15.77M | AU$ -20.04M | AU$ -16.70M |
| Net Income | AU$ -7.71M | AU$ -17.84M | AU$ -17.53M | AU$ -20.82M | AU$ -16.77M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 141.46K | AU$ 1.02M | AU$ 702.87K | AU$ 239.82K | AU$ 1.79M |
| Total Assets | AU$ 1.29M | AU$ 2.47M | AU$ 10.79M | AU$ 9.88M | AU$ 23.55M |
| Total Debt | AU$ 9.59M | AU$ 8.29M | AU$ 1.04M | AU$ 575.14K | AU$ 4.39M |
| Net Debt | AU$ 9.45M | AU$ 7.26M | AU$ 341.85K | AU$ 335.32K | AU$ 2.61M |
| Total Liabilities | AU$ 10.74M | AU$ 11.10M | AU$ 16.61M | AU$ 18.02M | AU$ 13.66M |
| Stockholders' Equity | AU$ -9.45M | AU$ -8.63M | AU$ -5.15M | AU$ -7.51M | AU$ 11.23M |
| Cash Flow | |||||
| Free Cash Flow | AU$ -4.03M | AU$ -9.28M | AU$ -14.80M | AU$ -12.18M | AU$ -14.85M |
| Operating Cash Flow | AU$ -4.03M | AU$ -9.28M | AU$ -14.66M | AU$ -11.99M | AU$ -12.16M |
| Investing Cash Flow | AU$ -721.00 | AU$ 208.83K | AU$ -140.12K | AU$ 606.20K | AU$ -1.11M |
| Financing Cash Flow | AU$ 3.14M | AU$ 9.39M | AU$ 15.27M | AU$ 9.73M | AU$ 9.74M |
Argent Biopharma (DE:H5O0)
FRANKFURT:H5O0
